Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LISA Trial
PACTR202206713343239Not yet recruiting
- Sponsor
- FHI 360
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of avatrombopag in anaemia (2 arms), sponsored by FHI 360. Primary endpoint: Mean change in hemoglobin. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
avatrombopag
03
Conditions
anaemia
Beyond the preview
Go deeper on PACTR202206713343239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202206713343239.